Analysts Offer Insights on Healthcare Companies: Cigna (CI), Cogent Biosciences (COGT) and Canopy Growth (CGC)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cigna (CI – Research Report), Cogent Biosciences (COGT – Research Report) and Canopy Growth (CGC – Research Report).

Cigna (CI)

In a report released yesterday, Ben Hendrix from RBC Capital upgraded Cigna to Buy, with a price target of $354.00. The company’s shares closed last Monday at $342.31, close to its 52-week high of $347.14.

According to TipRanks.com, Hendrix is a 3-star analyst with an average return of 2.5% and a 57.9% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Brookdale Senior Living, and Universal Health.

Currently, the analyst consensus on Cigna is a Strong Buy with an average price target of $366.69, a 6.4% upside from current levels. In a report issued on February 12, TD Cowen also maintained a Buy rating on the stock with a $400.00 price target.

See the top stocks recommended by analysts >>

Cogent Biosciences (COGT)

LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Cogent Biosciences today and set a price target of $16.00. The company’s shares closed last Monday at $7.50.

According to TipRanks.com, Slutsky is a 5-star analyst with an average return of 17.7% and a 51.2% success rate. Slutsky covers the Healthcare sector, focusing on stocks such as Abivax SA Sponsored ADR, Olema Pharmaceuticals, and ALX Oncology Holdings.

Cogent Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $15.00, a 106.9% upside from current levels. In a report issued on February 12, Needham also maintained a Buy rating on the stock with a $15.00 price target.

Canopy Growth (CGC)

Jefferies analyst Owen Bennett maintained a Hold rating on Canopy Growth yesterday and set a price target of C$7.28. The company’s shares closed last Monday at $3.47, close to its 52-week low of $3.21.

According to TipRanks.com, Bennett is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -10.7% and a 33.2% success rate. Bennett covers the Healthcare sector, focusing on stocks such as Cannabist Company Holdings, Aurora Cannabis, and Cresco Labs.

Canopy Growth has an analyst consensus of Moderate Sell, with a price target consensus of $4.15.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CI:

• The Cigna Group Announces Pricing Terms of Tender Offers
• The Cigna Group Announces Early Results of Tender Offers and Upsize of Maximum Tender Offer
• Cigna Corp Initiates $3.2 Billion Accelerated Stock Buyback
• Cigna announces $3.2B accelerated stock repurchase
• Cigna Corp Announces $4.5 Billion Senior Notes Offering